{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:59:32Z","timestamp":1775059172360,"version":"3.50.1"},"reference-count":31,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202365009","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T18:28:02Z","timestamp":1675189682000},"source":"Crossref","is-referenced-by-count":3,"title":["Cost-effectiveness analysis and budgetary impact of anidulafungin treatment for patients with candidemia and other forms of invasive candidiasis in Brazil"],"prefix":"10.1590","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0252-1144","authenticated-orcid":false,"given":"Cid Manso de Mello","family":"Vianna","sequence":"first","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5954-684X","authenticated-orcid":false,"given":"Gabriela Bittencourt Gonzalez","family":"Mosegui","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6043-8528","authenticated-orcid":false,"given":"Marcus Paulo da Silva","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Marinha do Brasil,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"key":"ref1","series-title":"Nota t\u00e9cnica GVIMS\/GGTES\/ANVISA No 04\/2021: orienta\u00e7\u00f5es para vigil\u00e2ncia, identifica\u00e7\u00e3o, preven\u00e7\u00e3o e controle de infec\u00e7\u00f5es f\u00fangicas invasivas em servi\u00e7os de sa\u00fade no contexto da pandemia da COVID-19"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas PG","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","article-title":"ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients","volume":"45","author":"Martin-Loeches I","year":"2019","journal-title":"Intensive Care Med"},{"key":"ref4","series-title":"Candid\u00edase sist\u00eamica"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","article-title":"Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers","volume":"44","author":"Colombo AL","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref6","series-title":"Invasive Candidiasis statistics"},{"key":"ref7","series-title":"Rela\u00e7\u00e3o nacional de medicamentos essenciais: 2022","year":"2022"},{"key":"ref8","article-title":"Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species","volume":"17","author":"Ou HT","year":"2017","journal-title":"BMC Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/jac\/dkr186","article-title":"Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis","volume":"66","author":"Neoh CF","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref10","first-page":"527","article-title":"Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and\/or invasive candidiasis in nonneutropenic adult patients","volume":"7","author":"Grau S","year":"2015","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus Fluconazole for Invasive Candidiasis","volume":"356","author":"Reboli AC","year":"2007","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1143-1","article-title":"Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis","volume":"15","author":"Auzinger G","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-0711-8-23","article-title":"Antifungal treatment for invasive Candida infections: A mixed treatment comparison meta-analysis","volume":"8","author":"Mills EJ","year":"2009","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.01657-09","article-title":"Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection","volume":"54","author":"Wang JL","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1086\/429330","article-title":"Treatment of Candida Infections with Amphotericin B Lipid Complex","volume":"40","author":"Ito JI","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref16","series-title":"Banco de pre\u00e7os em sa\u00fade"},{"key":"ref17","series-title":"SIGTAP: sistema de gerenciamento da tabela de procedimentos, medicamentos e OPM do SUS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2141.1998.00944.x","article-title":"Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections","volume":"103","author":"Leenders AC","year":"1998","journal-title":"Br J Haematol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.diagmicrobio.2013.04.001","article-title":"Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex","volume":"76","author":"Wade RL","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2147\/TCRM.S1554","article-title":"Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate","volume":"4","author":"Chandrasekar PH","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson TF","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh TJ","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1086\/429329","article-title":"Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry","volume":"40","author":"Pappas PG","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/myc.12283","article-title":"Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study","volume":"58","author":"Falci DR","year":"2015","journal-title":"Mycoses"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1517\/14656566.4.8.1277","article-title":"The lipid formulations of amphotericin B","volume":"4","author":"Herbrecht R","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-3062.1999.010406.x","article-title":"Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability","volume":"1","author":"Tiphine M","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"Hamill RJ","year":"2013","journal-title":"Drugs"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00019053-200422050-00004","article-title":"Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections","volume":"22","author":"Kuti JL","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40258-013-0072-7","article-title":"Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States","volume":"12","author":"Yang H","year":"2014","journal-title":"Appl Health Econ Health Policy"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","article-title":"Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers","volume":"44","author":"Colombo AL","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e0146909","DOI":"10.1371\/journal.pone.0146909","article-title":"Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian national surveillance program","volume":"11","author":"Doi AM","year":"2016","journal-title":"PLoS One"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652023000100203&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T17:29:11Z","timestamp":1678814951000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652023000100203&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":31,"alternative-id":["S0036-46652023000100203"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202365009","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e9"}}